Literature DB >> 15245870

Tumor necrosis factor-alpha downregulates adrenomedullin receptors in human coronary artery smooth muscle cells.

Yasuko Nagoshi1, Kenji Kuwasako, Yuan-Ning Cao, Takuroh Imamura, Kazuo Kitamura, Tanenao Eto.   

Abstract

We examined the effects of tumor necrosis factor (TNF)-alpha on the expression and functionality of adrenomedullin (AM) receptors in cultured human coronary artery smooth muscle cells. Analysis of real-time quantitative polymerase chain reactions showed that these cells abundantly express two AM receptors comprised of calcitonin receptor-like receptor (CRLR) and receptor activity-modifying protein 1 (RAMP1) or RAMP2. TNF-alpha induced time- and dose-dependent decreases in the expression of CRLR and RAMP1/2 mRNAs, thereby diminishing AM-evoked cAMP production. The suppression of these three mRNAs was unaffected by inhibiting NOS, protein kinase G, protein kinase A, superoxide formation or NF-kappaB activation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15245870     DOI: 10.1016/j.peptides.2004.04.010

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  3 in total

1.  Adrenomedullin improves the blood-brain barrier function through the expression of claudin-5.

Authors:  Masaru Honda; Shinsuke Nakagawa; Kentaro Hayashi; Naoki Kitagawa; Keisuke Tsutsumi; Izumi Nagata; Masami Niwa
Journal:  Cell Mol Neurobiol       Date:  2006-04-20       Impact factor: 5.046

2.  AM₁-receptor-dependent protection by intermedin of human vascular and cardiac non-vascular cells from ischaemia-reperfusion injury.

Authors:  David Bell; Malcolm Campbell; Matthew Ferguson; Leah Sayers; Liz Donaghy; Anna O'Regan; Victoria Jewhurst; Mark Harbinson
Journal:  J Physiol       Date:  2011-12-19       Impact factor: 5.182

3.  Mice heterozygous for adrenomedullin exhibit a more extreme inflammatory response to endotoxin-induced septic shock.

Authors:  Ryan Dackor; Kathleen Caron
Journal:  Peptides       Date:  2007-08-21       Impact factor: 3.750

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.